PAYDAŞ, S. 2019. Management of adverse effects/toxicity of ibrutinib. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.136 , 56-63.

PAYDAŞ, S., (2019). Management of adverse effects/toxicity of ibrutinib. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.136, 56-63.

PAYDAŞ, SEMRA. "Management of adverse effects/toxicity of ibrutinib," CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.136, 56-63, 2019

PAYDAŞ, SEMRA. "Management of adverse effects/toxicity of ibrutinib." CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.136, pp.56-63, 2019

PAYDAŞ, S. (2019) . "Management of adverse effects/toxicity of ibrutinib." CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.136, pp.56-63.

@article{article, author={SEMRA PAYDAŞ}, title={Management of adverse effects/toxicity of ibrutinib}, journal={CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY}, year=2019, pages={56-63} }